Published :
Tables : 320
Figures : 50
Category : Healthcare
No. of Pages : 250
Report Code : HC-1269
Biosurgery Market Introduction: Biosurgery Market is predicted to arrive at a value of USD 19.5 billion by the year end of 2027, along with a CAGR of over 6% during the forecast period 2020 to 2027. The growth of the geriatric population, coupled with the rise in the sheer number of sports-related injuries and surgeries, the need for adequate patient blood loss management, the increase in the clearance of biosurgery products by regulatory authorities are all factors that have played a role in the potential growth of the market. The market has much economic scope as new products and applications have been introduced. These biosurgery products are found in numerous applications ranging from gynecological surgery, orthopedic surgery, general surgery, cardiovascular surgery, neurological surgery, urological surgery, thoracic surgery and reconstructive surgery. Based on the segmentation, the market involves products such as surgical sealants and adhesives, soft tissue attachments, staple line reinforcement agents, bone graft substitutes, and hemostatic agents and adhesion barriers. The growing demand for hydrogel-based polymeric sealants has also been instrumental in the meteoric augmentation of the biosurgery market. The Asia Pacific market region has been anticipated to register a high CAGR value over the forecast time frame. The APAC market is growing rapidly particularly in terms of biosurgery products. It's important to note that the ever-expanding healthcare expenditure, rising need for managing blood loss effectively and the growing number of surgical procedures are factors which have enhanced the market growth in the region. Large networks of key market players as well as the presence of native players and the growing prevalence of biosurgery products, are aspects which have been instrumental to the potential of the market. Therefore, the Asia Pacific region holds a substantial global biosurgery market share. Key players of the biosurgery industry are Baxter International (US), C.R. Bard (US), Medtronic (Ireland), MAQUET Holding (Germany), CryoLife (US), Stryker Corporation (US), Integra Lifesciences (US), Pfizer (US), CSL Limited (Australia), Johnson & Johnson (US), Sanofi (France), Cohera Medical (US), Hemostasis (US), B. Braun (Germany). Biosurgery Market Segmentation: By Product Type Bone-Graft Substitutes Demineralized Bone Matrix Synthetic Bone Grafts Bone Morphogenetic Proteins Other Bone-Graft Substitutes Soft-Tissue Attachments Synthetic Meshes Biological Meshes Allografts Xenografts Hemostatic Agents Thrombin-Based Hemostatic Agents Oxidized Regenerated Cellulose-Based Hemostatic Agents Combination Hemostatic Agents Surgical Sealants and adhesives Natural/Biological Sealants and Adhesives Natural/Biological Sealants, By Type Fibrin Sealants Collagen Based Sealants Gelatin Based Sealants Albumin Based Sealants Others (Polysaccharide based sealants such as chitosan based sealants, dextran-based and chondroitin-based sealants) Natural/Biological Sealants, By Origin Human Blood Based Animal Based Sealants Synthetic/Semi-synthetic Sealants Cyanoacrylate-Based Sealants and Adhesives Peg Hydrogels Urethane-Based Sealants and Adhesives Other Synthetic and Semi-Synthetic Sealants and Adhesives Adhesion Barriers Synthetic Adhesion Barriers Hyaluronic Acid Regenarated Cellulose Polyethylene Glycol (PEG) Others Natural Adhesion Barriers Collagen & Protein Fibrin Based Staple-Line Reinforcement Agents By Application: Orthopedic Surgery General Surgery Neurological Surgery Cardiovascular Surgery Reconstructive Surgery Gynecological Surgery Urological Surgery Thoracic Surgery By Region: North America Europe Asia Pacific Latin America The Middle East and Africa FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global bio surgery market by product type, by application and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and the Middle East & Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization services offered are free of charge with purchase of any license of the report. You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Biosurgery Market is predicted to arrive at a value of USD 19.5 billion by the year end of 2027, along with a CAGR of over 6% during the forecast period 2020 to 2027.
The growth of the geriatric population, coupled with the rise in the sheer number of sports-related injuries and surgeries, the need for adequate patient blood loss management, the increase in the clearance of biosurgery products by regulatory authorities are all factors that have played a role in the potential growth of the market. The market has much economic scope as new products and applications have been introduced. These biosurgery products are found in numerous applications ranging from gynecological surgery, orthopedic surgery, general surgery, cardiovascular surgery, neurological surgery, urological surgery, thoracic surgery and reconstructive surgery.
Based on the segmentation, the market involves products such as surgical sealants and adhesives, soft tissue attachments, staple line reinforcement agents, bone graft substitutes, and hemostatic agents and adhesion barriers. The growing demand for hydrogel-based polymeric sealants has also been instrumental in the meteoric augmentation of the biosurgery market.
The Asia Pacific market region has been anticipated to register a high CAGR value over the forecast time frame. The APAC market is growing rapidly particularly in terms of biosurgery products. It's important to note that the ever-expanding healthcare expenditure, rising need for managing blood loss effectively and the growing number of surgical procedures are factors which have enhanced the market growth in the region. Large networks of key market players as well as the presence of native players and the growing prevalence of biosurgery products, are aspects which have been instrumental to the potential of the market. Therefore, the Asia Pacific region holds a substantial global biosurgery market share.
Key players of the biosurgery industry are Baxter International (US), C.R. Bard (US), Medtronic (Ireland), MAQUET Holding (Germany), CryoLife (US), Stryker Corporation (US), Integra Lifesciences (US), Pfizer (US), CSL Limited (Australia), Johnson & Johnson (US), Sanofi (France), Cohera Medical (US), Hemostasis (US), B. Braun (Germany).
Biosurgery Market Segmentation:
By Product Type
By Application:
By Region:
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Biosurgery Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Biosurgery Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Biosurgery Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Biosurgery Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Biosurgery Market, By Product Type Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Bone-Graft Substitutes 7.1.1 Demineralized Bone Matrix 7.1.2 Synthetic Bone Grafts 7.1.3 Bone Morphogenetic Proteins 7.1.4 Other Bone-Graft Substitutes 7.2. Soft-Tissue Attachments 7.2.1 Synthetic Meshes 7.2.2 Biological Meshes 7.2.2.1 Allografts 7.2.2.2 Xenografts 7.3 Hemostatic Agents 7.3.1 Thrombin-Based Hemostatic Agents 7.3.2 Oxidized Regenerated Cellulose-Based Hemostatic Agents 7.3.3 Combination Hemostatic Agents 7.4 Surgical Sealants and Adhesives 7.4.1 Natural/Biological Sealants and Adhesives 7.4.1.1 Natural/Biological Sealants and Adhesives, By Type 7.4.1.1.1 Fibrin Sealants 7.4.1.1.2 Collagen-Based Sealants 7.4.1.1.3 Gelatin-Based Sealants 7.4.1.1.4 Albumin-Based Sealants 7.4.1.1.5 Other Natural/Biological Sealants 7.4.1.2 Natural/Biological Sealants and Adhesives, By Origin 7.4.1.2.1 Human Blood-Based Sealants and Adhesives 7.4.1.2.2 Animal-Based Sealants and Adhesives 7.4.2 Synthetic and Semi-Synthetic Sealants and Adhesives 7.4.2.1 Peg Hydrogels 7.4.2.2 Cyanoacrylate-Based Sealants and Adhesives 7.4.2.3 Urethane-Based Sealants and Adhesives 7.4.2.4 Other Synthetic and Semi-Synthetic Sealants and Adhesives 7.5 Adhesion Barriers 7.5.1 Synthetic Adhesion Barriers 7.5.1.1 Hyaluronic Acid-Based Adhesion Barriers 7.5.1.2 Regenerated Cellulose-Based Adhesion Barriers 7.5.1.3 Peg-Based Adhesion Barriers 7.5.1.4 Ther Synthetic Adhesion Barriers 7.5.2 Natural Adhesion Barriers 7.5.2.1 Collagen & Protein Adhesion Barriers 7.5.2.2 Fibrin-Based Adhesion Barriers 7.6 Staple-Line Reinforcement Agents 8. Global Biosurgery Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Orthopedic Surgery 8.2. General Surgery 8.3. Neurological Surgery 8.4. Cardiovascular Surgery 8.5. Reconstructive Surgery 8.6. Gynecological Surgery 8.7. Urological Surgery 8.8. Thoracic Surgery 9. North America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico 9.3. Market Size (USD Million) Forecast for North America 2020-2027 10. Latin America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 10.2.1. Brazil 10.2.2. Venezuela 10.2.3. Argentina 10.2.4. Rest of Latin America 10.3. Market Size (USD Million) Forecast for Latin America 2020-2027 11. Europe Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Rest of Europe 11.3. Market Size (USD Million) Forecast for Europe 2020-2027 12. Asia Pacific Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 12.2.1. Japan 12.2.2. China 12.2.3. India 12.2.4. Australia and New Zealand 12.2.5. ASEAN 12.2.6. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 13. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Saudi Arabia 13.2.2. UAE 13.2.3. South Africa 13.2.4. Egypt 13.3. Market Size (USD Million) Forecast for MEA 2020-2027 14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 14.1. Baxter International (US) 14.1.1. Company Overview 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2. C.R. Bard (US) 14.2.1. Company Overview 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3. Medtronic (Ireland) 14.3.1. Company Overview 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4. MAQUET Holding (Germany) 14.4.1. Company Overview 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5. CryoLife (US) 14.5.1. Company Overview 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 14.6. Stryker Corporation (US) 14.6.1. Company Overview 14.6.2. Product Portfolio 14.6.3. SWOT Analysis 14.6.4. Financial Overview 14.6.5. Strategic Overview 14.7. Integra Lifesciences (US) 14.7.1. Company Overview 14.7.2. Product Portfolio 14.7.3. SWOT Analysis 14.7.4. Financial Overview 14.7.5. Strategic Overview 14.8. Pfizer (US) 14.8.1. Company Overview 14.8.2. Product Portfolio 14.8.3. SWOT Analysis 14.8.4. Financial Overview 14.8.5. Strategic Overview 14.9. CSL Limited (Australia) 14.9.1. Company Overview 14.9.2. Product Portfolio 14.9.3. SWOT Analysis 14.9.4. Financial Overview 14.9.5. Strategic Overview 14.10. Johnson & Johnson (US) 14.10.1. Company Overview 14.10.2. Product Portfolio 14.10.3. SWOT Analysis 14.10.4. Financial Overview 14.10.5. Strategic Overview 14.11. Sanofi (France) 14.11.1. Company Overview 14.11.2. Product Portfolio 14.11.3. SWOT Analysis 14.11.4. Financial Overview 14.11.5. Strategic Overview 14.12. Cohera Medical (US) 14.12.1. Company Overview 14.12.2. Product Portfolio 14.12.3. SWOT Analysis 14.12.4. Financial Overview 14.12.5. Strategic Overview 14.13. Hemostasis (US) 14.13.1. Company Overview 14.13.2. Product Portfolio 14.13.3. SWOT Analysis 14.13.4. Financial Overview 14.13.5. Strategic Overview 14.14. B. Braun (Germany) 14.14.1. Company Overview 14.14.2. Product Portfolio 14.14.3. SWOT Analysis 14.14.4. Financial Overview 14.14.5. Strategic Overview 15. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics